The effect of weight reduction by dietary restriction on exercise blood pressure (BP) was studied in ten volunteers with a body mass index (BMI) 425 kg/ m 2 . By weight reduction (on average 11.5%), resting systolic/diastolic BP decreased from 137715/ 84710 to 124711/7779 mm Hg (Po0.001 for systolic and Po0.01 for diastolic BP), and peak exercise systolic/diastolic BP decreased from 221722/86713 to 200724/79721 mm Hg (Po0.01 for systolic and P ¼ 0.08 for diastolic BP). A moderate weight reduction lowers BP at rest and during exercise testing by approximately 8-10%.
Overweight is amongst the strongest risk factors for hypertension. [1] [2] [3] Previous studies proved that weight reduction lowers resting BP. [4] [5] [6] In contrast, only one previous study assessed the effect of weight reduction on exercise BP and found a decrease. 7 The generalizability of that study is limited as participants were morbidly obese and weight reduction was achieved by surgical gastric restriction. However, exercise BP is of interest as systolic exercise BP was shown to predict end organ damage and cardiovascular mortality. [8] [9] Results from resting BP cannot be generalized to exercise BP since physiological mechanisms of the two entities are dissimilar. 10 We, therefore, assessed the effect of a moderate weight reduction using dietary restriction on lowering exercise BP in a group of overweight volunteers.
Volunteers with a BMI 425 kg/m 2 were invited to participate in the study. Of 17 eligible volunteers, six had to be excluded as one or more predefined exclusion criteria were met. These criteria comprised lacking volition to reduce weight, severe hypertension (systolic BPX160 or diastolic BPX100 mm Hg), history of cardiovascular or pulmonary disease, intake of drugs and pregnancy. The local Ethical Committee approved the protocol and each subject gave written informed consent.
The baseline examination (before weight reduction) was performed by the evaluation personnel (physician and nurses). It comprised a resting ECG, BP measurements at rest, a 24 h ambulatory BP monitoring (ABPM), and an exercise test. Resting BP and ABPM were measured with automated systems using the oscillometric method (Spot Vital Signs, Welch Allyn, Skaneateles Falls, USA; BR-102 plus, Schiller AG, Baar, Switzerland). Exercise BP was measured with a fully automated system (Cardiovit CS-200, Schiller AG, Baar, Switzerland). The workload was increased according to a defined ramp protocol by 20 W/min to the maximal tolerated level. BP was measured once per exercise intensity with a standardized timing. Physical activity during 2 subsequent days was assessed by pedometer (Bodywatch, Kasper&Richter, Uttenreuth, Germany).
After the baseline examination, all participants received dietary counselling by the intervention personnel (physician and dieticians). The counselling comprised a protein sparing modified fasting (ketogenic diet). The ketogenic diet prescribes food high in fat and restricts carbohydrate intake. The participants were instructed to continue their exercise habits. No attempt was made to change their smoking or drinking habits during the diet. All participants were contacted by phone every 8 to 12 weeks to assess weight loss and to invite them for further dietary counselling if necessary. The followup examination was scheduled as soon as the reported weight reduction exceeded 5% of the baseline body weight. The followup examination was identical to the baseline examination and was performed by the evaluation personnel.
Results are expressed as mean7s.d. Mean arterial BP was defined as diastolic BP plus one-third of the difference between systolic and diastolic BP. Paired t-test was used for comparisons between BP levels after checking for normal distribution. Values of Po0.05 were considered to indicate statistical significance.
Ten of 11 recruited subjects lost at least 5% of their initial weight. One subject was excluded from the analysis because he failed to lose weight and lost his volition to continue (weight at enrolment was 91 and 90 kg at last followup). The mean age of the remaining 10 study participants was 36.679.7 years (range 24-50 years): two were women and eight were male. Five participants were current smokers. Systolic/mean/diastolic BP at rest in the seated position was 137715/102711/84710 mm Hg before and 124711/9279/7779 mm Hg after weight reduction (Po0.001 for systolic and mean, and Po0.01 for diastolic BP). Heart rate per minute at rest decreased from 83713 to 74713 (P ¼ 0.01). ABPM revealed significant differences for the average day time BP before and after weight reduction: average day time systolic/mean/diastolic BP decreased from 132714/10279/8877 to 12278/9576/8277 mm Hg (Po0.05 for systolic and mean and Po0.01 for diastolic BP). Six subjects with systolic BP between 140 and 159 mm Hg and/or diastolic BP between 90 and 99 mm Hg during resting BP measurement at enrolment had hypertension at baseline according to diagnostic criteria. After weight reduction, only one patient fulfilled the same criteria for having hypertension (McNemar's test P ¼ 0.03).
BP and heart rate during exercise testing are shown in Figure 1 . Peak exercise systolic/mean/ diastolic BP was 221722/13178/86713 mm Hg before, and 200724/119713/79721 mm Hg after weight reduction (Po0.01 for systolic, Po0.05 for mean and P ¼ 0.08 for diastolic BP), whereas peak exercise work rate (256734 versus 248739 W) was not different (P ¼ 0.12). Peak exercise heart rate per minute was 180715 before and 176716 after weight reduction (P ¼ 0.08).
Our study shows that a moderate 11.5% weight reduction by dietary restriction results in a decrease of systolic, mean and diastolic BP by 8-10% both at rest and during exercise testing. We believe that our study is the first to investigate effects of a moderate weight reduction by dietary restriction on exercise BP in overweight subjects. Only one previous study assessed the effect of a 28% weight reduction through surgical gastric restriction on exercise BP which decreased on average by 10.5%. 7 Our study demonstrates that a less pronounced reduction in weight can result in a similar relative reduction in exercise BP. The main limitation of this small clinical trial is the lack of a control group. It is therefore conceivable that unmeasured factors may have influenced our study findings. We controlled for physical activity, smoking status, alcohol intake, and drug therapy. Changes in sodium intake during the diet were not assessed and could have influenced BP results. However, the amount of BP reduction at rest corresponded to the results reported in previous randomized controlled studies. [4] [5] [6] Furthermore, we observed a significant reduction of heart rate suggesting a decrease of sympathetic tone, which was shown to have a role in obesity-associated hypertension.
11 Therefore, the BP reduction was most probably induced by weight reduction. A further limitation was the small number of study participants. As a consequence, it was not possible to perform subgroup analysis or adjust results for possible confounders in regression analysis (e.g. smoking status). But for the main purpose of our study, power analysis assuming a 10% reduction of BP showed a sufficient power with our sample size of 10 study participants. Study participants were rather young and rather healthy. Therefore, our results should be generalized with caution to a population with severe cardiovascular disease or to the elderly.
In conclusion, a moderate weight reduction by dietary restriction lowers BP at rest and during exercise by approximately 8-10%, which is as efficacious as a single-drug antihypertensive therapy. Theoretically, our results would translate into a considerable cardiovascular risk reduction with about one-third fewer major cardiovascular events overall. 12 
